OpGen to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
GAITHERSBURG, Md., Aug. 29, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) announced today that Evan Jones, Chairman and Chief Executive Officer, will present a corporate overview at the 20th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co. The conference is being held September 4-6, 2018 at the St. Regis New York Hotel in New York City, and OpGen’s presentation will be on September 6 at 10:50 a.m. Eastern time.
To listen to the live presentation, investors may visit the Investor Relations section of OpGen’s website at www.opgen.com. An archived webcast of the presentation will also be available on the Company’s website for a period of time.
About OpGen
OpGen, Inc. is harnessing the power of informatics and genomic analysis to provide complete solutions for patient, hospital and network-wide infection prevention and treatment. For more information, please visit www.opgen.com.
OpGen Contact:
Michael Farmer
Vice President, Marketing
(240) 813-1284
mfarmer@opgen.com
InvestorRelations@opgen.com
Investor Contacts:
LHA Investor Relations
Kim Sutton Golodetz
(212) 838-3777
kgolodetz@lhai.com
or
Bruce Voss
(310) 691-7100
bvoss@lhai.com
